Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 3
2015 1
2016 8
2017 7
2018 13
2019 12
2020 11
2021 19
2022 20
2023 13
2024 9
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

96 results

Results by year

Filters applied: . Clear all
Page 1
Molecular Hallmarks of Prostate-specific Membrane Antigen in Treatment-naïve Prostate Cancer.
Weiner AB, Agrawal R, Wang NK, Sonni I, Li EV, Arbet J, Zhang JJH, Proudfoot JA, Hong BH, Davicioni E, Kane N, Valle LF, Kishan AU, Pra AD, Ghadjar P, Sweeney CJ, Nickols NG, Karnes RJ, Shen J, Rettig MB, Czernin J, Ross AE, Lee Kiang Chua M, Schaeffer EM, Calais J, Boutros PC, Reiter RE. Weiner AB, et al. Among authors: proudfoot ja. Eur Urol. 2024 Dec;86(6):579-587. doi: 10.1016/j.eururo.2024.09.005. Epub 2024 Sep 17. Eur Urol. 2024. PMID: 39294048 Free PMC article.
OCT Angiography Artifacts in Glaucoma.
Kamalipour A, Moghimi S, Hou H, Penteado RC, Oh WH, Proudfoot JA, El-Nimri N, Ekici E, Rezapour J, Zangwill LM, Bowd C, Weinreb RN. Kamalipour A, et al. Among authors: proudfoot ja. Ophthalmology. 2021 Oct;128(10):1426-1437. doi: 10.1016/j.ophtha.2021.03.036. Epub 2021 Apr 2. Ophthalmology. 2021. PMID: 33819524 Free PMC article.
Development of a Longitudinal Prostate Cancer Transcriptomic and Clinical Data Linkage.
Leapman MS, Ho J, Liu Y, Filson CP, Zhao X, Hakansson A, Proudfoot JA, Davicioni E, Martin DT, An Y, Seibert TM, Lin DW, Spratt DE, Cooperberg MR, Ross AE, Sprenkle PC. Leapman MS, et al. Among authors: proudfoot ja. JAMA Netw Open. 2024 Jun 3;7(6):e2417274. doi: 10.1001/jamanetworkopen.2024.17274. JAMA Netw Open. 2024. PMID: 38874922 Free PMC article.
Gene-Environment Interactions in Progressive Supranuclear Palsy.
Litvan I, Proudfoot JA, Martin ER, Standaert D, Riley D, Hall D, Marras C, Bayram E, Dubinsky RM, Bordelon Y, Reich S, Shprecher D, Kluger B, Cunningham C, Schellenberg GD, Jankovic J. Litvan I, et al. Among authors: proudfoot ja. Front Neurol. 2021 Apr 9;12:664796. doi: 10.3389/fneur.2021.664796. eCollection 2021. Front Neurol. 2021. PMID: 33897612 Free PMC article.
Phase II Randomized Study of Salvage Radiation Therapy Plus Enzalutamide or Placebo for High-Risk Prostate-Specific Antigen Recurrent Prostate Cancer After Radical Prostatectomy: The SALV-ENZA Trial.
Tran PT, Lowe K, Tsai HL, Song DY, Hung AY, Hearn JWD, Miller S, Proudfoot JA, Deek MP, Phillips R, Lotan T, Paller CJ, Marshall CH, Markowski M, Dipasquale S, Denmeade S, Carducci M, Eisenberger M, DeWeese TL, Orton M, Deville C, Davicioni E, Liauw SL, Heath EI, Greco S, Desai NB, Spratt DE, Feng F, Wang H, Beer TM, Antonarakis ES. Tran PT, et al. Among authors: proudfoot ja. J Clin Oncol. 2023 Feb 20;41(6):1307-1317. doi: 10.1200/JCO.22.01662. Epub 2022 Nov 11. J Clin Oncol. 2023. PMID: 36367998 Free PMC article. Clinical Trial.
Olaparib Without Androgen Deprivation for High-Risk Biochemically Recurrent Prostate Cancer Following Prostatectomy: A Nonrandomized Controlled Trial.
Marshall CH, Teply BA, Lu J, Oliveira L, Wang H, Mao SS, Kelly WK, Paller CJ, Markowski MC, Denmeade SR, King S, Sullivan R, Davicioni E, Proudfoot JA, Eisenberger MA, Carducci MA, Lotan TL, Antonarakis ES. Marshall CH, et al. Among authors: proudfoot ja. JAMA Oncol. 2024 Oct 1;10(10):1400-1408. doi: 10.1001/jamaoncol.2024.3074. JAMA Oncol. 2024. PMID: 39172479 Clinical Trial.
Tests for paired count outcomes.
Proudfoot JA, Lin T, Wang B, Tu XM. Proudfoot JA, et al. Gen Psychiatr. 2018 Sep 8;31(1):e100004. doi: 10.1136/gpsych-2018-100004. eCollection 2018. Gen Psychiatr. 2018. PMID: 30582120 Free PMC article.
Association Between the Decipher Genomic Classifier and Prostate Cancer Outcome in the Real-world Setting.
Leapman MS, Ho J, Liu Y, Filson C, Zhao X, Hakansson A, Proudfoot JA, Davicioni E, Martin DT, An Y, Seibert TM, Lin DW, Spratt DE, Cooperberg MR, Sprenkle PC, Ross AE. Leapman MS, et al. Among authors: proudfoot ja. Eur Urol Oncol. 2024 Aug 3:S2588-9311(24)00183-4. doi: 10.1016/j.euo.2024.07.010. Online ahead of print. Eur Urol Oncol. 2024. PMID: 39098389 Free article.
A novel prostate cancer subtyping classifier based on luminal and basal phenotypes.
Weiner AB, Liu Y, Hakansson A, Zhao X, Proudfoot JA, Ho J, Zhang JH, Li EV, Karnes RJ, Den RB, Kishan AU, Reiter RE, Hamid AA, Ross AE, Tran PT, Davicioni E, Spratt DE, Attard G, Lotan TL, Lee Kiang Chua M, Sweeney CJ, Schaeffer EM. Weiner AB, et al. Among authors: proudfoot ja. Cancer. 2023 Jul 15;129(14):2169-2178. doi: 10.1002/cncr.34790. Epub 2023 Apr 14. Cancer. 2023. PMID: 37060201 Free article.
96 results